
Adam Higgins is a life sciences and healthcare technology leader with over 23 years of experience across the pharmaceutical industry, digital health, clinical innovation and real-world evidence.
At Sanome, Adam leads the life sciences strategy, building partnerships with pharmaceutical companies, research organisations and healthcare systems to unlock the value of real-time clinical data. His focus is on advancing real-world evidence generation, accelerating clinical research and translating AI-driven insights into better clinical decisions and patient outcomes.
Prior to joining Sanome, Adam was Executive Director of Commercial and Medical Excellence at Johnson & Johnson Innovative Medicine EMEA, where he led regional transformation across commercial and medical operations, launch excellence, digital innovation and patient support programmes.
Adam previously spent 17 years at AstraZeneca, including leading Global Digital Innovation, where he established collaborations with leading academic institutions, healthcare systems and technology companies, including Duke, Imperial College London and Stanford Medicine. During the COVID-19 pandemic, he supported the NHS response by helping establish digitally enabled virtual ward pathways across North West London, work subsequently recognised with an HSJ Award.
Adam is also a Venture Partner at THENA Capital, supporting investment and growth strategies across healthtech, diagnostics and life sciences.
He is passionate about connecting the pharmaceutical industry with healthcare innovation, using real-world clinical data and emerging technologies to accelerate research, improve care and deliver meaningful value for patients and healthcare systems.